Hos de personer, der fik Volibris (kombineret dosis- gruppe), var den observerede sandsynlighed for overlevelse efter 1 år 95% og efter 2 år 84%.
The observed probability of survival at 1 year for subjects receiving Volibris (combined Volibris dose group) was 95% and at 2 years was 84%.